Literature DB >> 18093559

Alzheimer's disease funding and the French health system.

Laura Spinney1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18093559     DOI： 10.1016/S1474-4422(07)70315-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

1.  The course of primary progressive aphasia diagnosis: a cross-sectional study.

Authors:  A Mouton; A Plonka; R Fabre; T M Tran; P Robert; J Macoir; V Manera; A Gros
Journal:  Alzheimers Res Ther       Date:  2022-05-10       Impact factor: 8.823

2.  The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact.

Authors:  Nicole Haeffner-Cavaillon; Patrick Devos; Sylvie Ledoux; Joël Ménard
Journal:  Alzheimers Res Ther       Date:  2015-09-26       Impact factor: 6.982

3.  Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.

Authors:  Karim Tifratene; Valeria Manera; Roxane Fabre; Auriane Gros; Susanne Thummler; Christian Pradier; Philippe Robert; Renaud David
Journal:  Alzheimers Res Ther       Date:  2017-04-26       Impact factor: 6.982

4.  Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.

Authors:  A Mouton; F Blanc; A Gros; V Manera; R Fabre; E Sauleau; I Gomez-Luporsi; K Tifratene; L Friedman; S Thümmler; C Pradier; P H Robert; R David
Journal:  Alzheimers Res Ther       Date:  2018-09-12       Impact factor: 6.982
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.